Brian K Halak - Net Worth and Insider Trading
Brian K Halak Net Worth
The estimated net worth of Brian K Halak is at least $181 Million dollars as of 2024-04-26. Brian K Halak is the Director of Dicerna Pharmaceuticals Inc and owns about 2,605,685 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $100 Million. Brian K Halak is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $54 Million. Brian K Halak is also the 10% Owner of Zogenix Inc and owns about 824,073 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Besides these, Brian K Halak also holds Esperion Therapeutics Inc (ESPR) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) . Details can be seen in Brian K Halak's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian K Halak has not made any transactions after 2018-11-06 and currently still holds the listed stock(s).
Transaction Summary of Brian K Halak
Brian K Halak Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian K Halak owns 28 companies in total, including Alimera Sciences Inc (ALIM) , Obalon Therapeutics Inc (OBLN) , and Adynxx Inc (ADYX) among others .
Click here to see the complete history of Brian K Halak’s form 4 insider trades.
Insider Ownership Summary of Brian K Halak
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALIM | Alimera Sciences Inc | 2010-04-21 | director |
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ADYX | Adynxx Inc | 2019-05-03 | 10 percent owner |
DRNA | Dicerna Pharmaceuticals Inc | 2018-11-06 | director |
BNGO | Bionano Genomics Inc | 2018-08-21 | 10 percent owner |
OCRX | Ocera Therapeutics Inc | 2017-12-11 | 10 percent owner |
RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
EVOK | Evoke Pharma Inc | 2013-09-24 | 10 percent owner |
SNDX | Syndax Pharmaceuticals Inc | 2016-03-02 | 10 percent owner |
GKOS | Glaukos Corp | 2015-06-24 | 10 percent owner |
LIFE | aTyr Pharma Inc | 2015-05-06 | 10 percent owner |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 10 percent owner |
EVFM | Evofem Biosciences Inc | 2014-11-19 | 10 percent owner |
ATRA | Atara Biotherapeutics Inc | 2014-10-15 | 10 percent owner |
VCYT | Veracyte Inc | 2013-10-29 | 10 percent owner |
OTIC | Otonomy Inc | 2014-08-12 | 10 percent owner |
MRNS | Marinus Pharmaceuticals Inc | 2014-07-31 | 10 percent owner |
ALDX | Aldeyra Therapeutics Inc | 2014-05-01 | 10 percent owner |
AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
TNDM | Tandem Diabetes Care Inc | 2013-11-13 | 10 percent owner |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 10 percent owner |
ACHN | Achillion Pharmaceuticals Inc | 2013-01-18 | 10 percent owner |
CPXX | Celator Pharmaceuticals Inc | 2013-01-14 | 10 percent owner |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 10 percent owner |
ZGNX | Zogenix Inc | 2011-09-16 | 10 percent owner |
VNDA | Vanda Pharmaceuticals Inc | 2006-04-12 | director |
PRTK | Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner |
RSLS | Reshape Lifesciences Inc | 2016-10-05 | 10 percent owner |
Brian K Halak Latest Holdings Summary
Brian K Halak currently owns a total of 7 stocks. Among these stocks, Brian K Halak owns 2,605,685 shares of Dicerna Pharmaceuticals Inc (DRNA) as of November 6, 2018, with a value of $100 Million and a weighting of 55.16%. Brian K Halak owns 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 20, 2010, with a value of $54 Million and a weighting of 30.07%. Brian K Halak also owns 824,073 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 12.18%. The other 4 stocks Esperion Therapeutics Inc (ESPR) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) have a combined weighting of 2.59% among all his current holdings.
Latest Holdings of Brian K Halak
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DRNA | Dicerna Pharmaceuticals Inc | 2018-11-06 | 2,605,685 | 38.22 | 99,589,281 |
ACHN | Achillion Pharmaceuticals Inc | 2010-08-20 | 8,032,129 | 6.76 | 54,297,192 |
ZGNX | Zogenix Inc | 2010-11-29 | 824,073 | 26.68 | 21,986,268 |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 2,102,188 | 1.99 | 4,183,354 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,041,950 | 0.02 | 45,629 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
Holding Weightings of Brian K Halak
Brian K Halak Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian K Halak has made a total of 0 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 335,000 shares on November 6, 2018, which brought Brian K Halak around $4 Million.
According to the SEC Form 4 filings, Brian K Halak has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on August 20, 2010, which brought Brian K Halak around $0.
According to the SEC Form 4 filings, Brian K Halak has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost Brian K Halak around $9 Million.
More details on Brian K Halak's insider transactions can be found in the Insider Trading History of Brian K Halak table.Insider Trading History of Brian K Halak
- 1
Brian K Halak Trading Performance
GuruFocus tracks the stock performance after each of Brian K Halak's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian K Halak is 15.68%. GuruFocus also compares Brian K Halak's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian K Halak within 3 months outperforms 5 times out of 19 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian K Halak's insider trading performs compared to the benchmark.
Performance of Brian K Halak
Average Return
-5.07%
Outperforming Transactions
32%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 14.92 | 15.68 | 22.11 | -5.07 | -16.01 | -7.3 |
Relative Return to S&P 500(%) | 11.38 | 10.65 | 14.06 | -17.55 | -27.54 | -18.79 |
Brian K Halak Ownership Network
Ownership Network List of Brian K Halak
Ownership Network Relation of Brian K Halak
Brian K Halak Owned Company Details
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Brian K Halak is the director of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Brian K Halak made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
Brian K Halak Mailing Address
Above is the net worth, insider trading, and ownership report for Brian K Halak. You might contact Brian K Halak via mailing address: C/o Domain Associates, One Palmer Square, Princeton Nj 08542.